| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/26/2011 | EP2277910A1 Albumin fusion proteins |
| 01/26/2011 | EP2277907A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277906A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277905A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277904A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277903A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277902A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277901A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277900A1 Metastin derivative and use thereof |
| 01/26/2011 | EP2277898A2 Rapamycin analogues |
| 01/26/2011 | EP2277889A2 Fusion proteins of albumin and interferon beta |
| 01/26/2011 | EP2277888A2 Fusion proteins of albumin and erythropoietin |
| 01/26/2011 | EP2277887A2 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 01/26/2011 | EP2277885A1 Glycosylated indolecarbazoles, method for obtaining same and uses thereof |
| 01/26/2011 | EP2277884A1 Anthracycline antibiotic derivatives with high activity, preparation methods and uses thereof |
| 01/26/2011 | EP2277880A1 Macrolides with VEGF transcription suppression activity |
| 01/26/2011 | EP2277879A1 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 01/26/2011 | EP2277877A1 Quinazoline derivatives as kinase inhibitors |
| 01/26/2011 | EP2277876A1 Substituted pyrimidines for the treatment of cancer |
| 01/26/2011 | EP2277873A1 Intermediate compound for the preparation of halichondrin analogs |
| 01/26/2011 | EP2277867A2 Compounds, pharmaceutical compositions thereof and their use in treating cancer |
| 01/26/2011 | EP2277594A2 Lysis / resealing process and device for incorporating an active ingredient in erythrocytes |
| 01/26/2011 | EP2277552A1 Mnk kinase proteins and diabetes |
| 01/26/2011 | EP2277551A2 Cyclodextrin-based polymers for delivering the therapeutic agents covalently bound thereto |
| 01/26/2011 | EP2277542A1 Modified antibodies to prostrate-specific membrane antigen and uses thereof |
| 01/26/2011 | EP2277526A1 Pharmaceutical composition with tetrahydroisohumulone |
| 01/26/2011 | EP2277514A1 A method for chemoprevention of prostate cancer |
| 01/26/2011 | EP2277507A1 Method of producing a cationic liposomal preparation comprising a lipophilic compound |
| 01/26/2011 | EP2277506A1 Non-polar buccal spray of a sedative |
| 01/26/2011 | EP2276774A2 Therapeutic substances that modulate genome methylation |
| 01/26/2011 | EP2276767A1 Benzopyran and benzoxepin pi3k inhibitor compounds and methods of use |
| 01/26/2011 | EP2276765A1 Salinosporamide derivatives as proteasome inhibitors |
| 01/26/2011 | EP2276757A2 Macrocyclic compounds and methods of treatment |
| 01/26/2011 | EP2276750A2 Substituted pyrimidines and triazines and their use in cancer therapy |
| 01/26/2011 | EP2276748A1 Bicyclic nitrogen containing heterocyclic compounds for use as stearoyl coa desaturase inhibitors |
| 01/26/2011 | EP2276511A2 Compositions and methods for delivering inhibitory oligonucleotides |
| 01/26/2011 | EP2276506A1 Potent conjugates and hydrophilic linkers |
| 01/26/2011 | EP2276493A1 Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17 |
| 01/26/2011 | EP2276489A2 Pterin based therapies for inflammatory conditions |
| 01/26/2011 | EP2276487A1 Piperlongumine and piperlongumine analogs for use in the treatment of cancer |
| 01/26/2011 | EP2276486A2 Novel substituted imidazoquinolines |
| 01/26/2011 | EP2276480A2 Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases |
| 01/26/2011 | EP2004597B1 1alpha-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds with a 1,1-dimethylpropyl side chain |
| 01/26/2011 | EP2004156B1 Compositions for transfection of oligonucleotides active for gene silencing and their biological and therapeutical applications |
| 01/26/2011 | EP1861402B1 Isoflavonoid dimers |
| 01/26/2011 | EP1856061B1 Tetrahydro- and dihydroquinazolinones |
| 01/26/2011 | EP1786819B1 Dihydropteridinone derivatives, methods for the production thereof and their use as medicaments |
| 01/26/2011 | EP1725261B1 Use of agonists and antagonists of interleukin-33 (il-33) |
| 01/26/2011 | EP1660513B1 A ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 01/26/2011 | EP1539956B1 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 01/26/2011 | EP1496892B1 1h-benzo(f)indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 01/26/2011 | EP1446382B1 Anthranilic acid amides and their use as vegf receptor tyrosine kinase inhibitors |
| 01/26/2011 | EP1404365B1 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy |
| 01/26/2011 | CN1947721B Method for preparing epirubicin slow-release prepn |
| 01/26/2011 | CN1927861B Garcinia acid derivatives, preparation method and application thereof in pharmacy |
| 01/26/2011 | CN101959887A Pyrrolopyridines as kinase inhibitors |
| 01/26/2011 | CN101959886A Imidazo[1,2-a]pyridine-2-carboxamide derivatives, preparation thereof and application thereof in therapeutics |
| 01/26/2011 | CN101959885A Derivatives of N-heterocyclic-6-heterocyclic-imidazo[l,2- a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 01/26/2011 | CN101959884A Derivatives of 6-heterocyclic-imidazo[l,2-alpha]pyrroine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 01/26/2011 | CN101959865A Quinolines as inhibitors of farnesyl pyrophosphate synthase |
| 01/26/2011 | CN101959855A Azetidine-derived compounds, preparation method therefor and therapeutic use of same |
| 01/26/2011 | CN101959533A Use of pyrimidine derivatives for the treatment of EGFR dependent diseases or diseases that have acquired resistance to agents that target EGFR family members |
| 01/26/2011 | CN101959516A Methods of treating by inhibiting with quinaxoline inhibitors of PI3K-alpha |
| 01/26/2011 | CN101959501A Stabilized single-liquid pharmaceutical composition containing docetaxel |
| 01/26/2011 | CN101957379A HPPCn antibody, antisense oligonucleotide and application of RNA interference in tumor diagnosis and treatment |
| 01/26/2011 | CN101955997A Compositions and method for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene |
| 01/26/2011 | CN101955524A CNGH0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses |
| 01/26/2011 | CN101955515A Progesterone releasing hormone-methotrexate compound and pharmaceutical application thereof |
| 01/26/2011 | CN101955480A Pyrazolo [3,4-b] quinoline compound and preparation method thereof |
| 01/26/2011 | CN101955465A 5-fluoropyrimidine-4(3H)-ketone compound and preparation method and application thereof |
| 01/26/2011 | CN101955461A Hsp90 inhibitor Xbj-B11 and preparation method and application thereof |
| 01/26/2011 | CN101955442A Benzoyl fluorobenzene salicylamide compound and application thereof |
| 01/26/2011 | CN101954095A Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells |
| 01/26/2011 | CN101954091A Reducible and degradable polymer pre-medicament and preparation method thereof |
| 01/26/2011 | CN101954085A Method for preparing magnetic-targeted thermochemotherapy gold shell nano-drug delivery system |
| 01/26/2011 | CN101954077A Expression plasmid adjuvant for enhancing chemotherapeutic effect of tumor chemotherapeutics and preparation method thereof |
| 01/26/2011 | CN101954073A Novel anti-tumor cell vaccine and preparation method thereof |
| 01/26/2011 | CN101954070A Preparation method of composition of nano SOD and vegetable drugs and health-care food or extracts thereof |
| 01/26/2011 | CN101954069A Anticancer application of recombinant human manganese superoxide dismutase |
| 01/26/2011 | CN101954067A Aqueous solution of recombinant human serum albumin-interferon alpha fusion protein and preparation method thereof |
| 01/26/2011 | CN101954065A Recombinant human endostatin nanoparticle composition for injection and preparation method thereof |
| 01/26/2011 | CN101954052A Traditional Chinese medicine for treating cancers and preparation method thereof |
| 01/26/2011 | CN101954049A Chinese medicinal preparation for treating liver neoplasms |
| 01/26/2011 | CN101954048A Chinese medicinal formula for treating atrophic gastritis and precancerous lesion |
| 01/26/2011 | CN101954042A Tumor eliminating capsule |
| 01/26/2011 | CN101954026A Traditional Chinese medicine preparation for treating lung cancer and preparation method thereof |
| 01/26/2011 | CN101954022A Chinese medicinal composition for treating lung cancer |
| 01/26/2011 | CN101954016A Medicinal composition for treating cancers |
| 01/26/2011 | CN101953975A Oral Chinese medicinal herbal tablets for treating tumors and preparation method |
| 01/26/2011 | CN101953966A Novel medicament (dioxin antidote) for treating cancer |
| 01/26/2011 | CN101953964A Chinese patent medicine for treating early and middle stage breast cancer |
| 01/26/2011 | CN101953911A Chinese medicinal preparation for treating stomach cancer and preparation method thereof |
| 01/26/2011 | CN101953900A Rumex gmelinii extract and application of effective part of rumex gmelinii to preparing antitumor medicament |
| 01/26/2011 | CN101953853A Preparation method of purified and deleaded propolis powder and propolis product |
| 01/26/2011 | CN101953850A Preparation method and application of oyster shell extract |
| 01/26/2011 | CN101953848A Medicament for treating cancer and application thereof |
| 01/26/2011 | CN101953847A Application of zinc hydroxide in preparation of anti-cancer drugs |
| 01/26/2011 | CN101953845A Transcatheter arterial chemoembolization embolism agent containing autophagy inhibitor |
| 01/26/2011 | CN101953839A Compound medicinal composition with effect of resisting acute myeloid leukemia |
| 01/26/2011 | CN101953829A Application of imperatorin in preparing antineoplastic medicine |